Unlock instant, AI-driven research and patent intelligence for your innovation.

siRNA for treating HBV

A HBV, treatment technology, applied in the field of genetic engineering, can solve the problems of immune tolerance, chronic HBV patients to obtain expected results, etc.

Inactive Publication Date: 2012-07-04
SHANDONG UNIV
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of the chronic HBV patients did not get the expected results under conventional treatment
Although interferon can inhibit the replication of HBV, HBV can resist the body's antiviral mechanism by inhibiting the secretion and function of interferon, and eventually lead to the body in a state of immune tolerance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • siRNA for treating HBV
  • siRNA for treating HBV
  • siRNA for treating HBV

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses siRNA (small interfering RNA) for treating HBV (hepatitis B virus), which has a sequence shown in SEQ ID NO.3. The siRNA can be artificially synthesized or synthesized through in vivo transcription. After the siRNA transfects HepG2.2.15 cell for 24 hours and 48 hours, the siRNA can reduce the expression of HBx gene, the content of HBsAg and HBeAg in the cell and supernate is also obviously reduced, and the effect of 3p-siRNA is more obvious than that of chemically synthesized siRNA. The siRNA can be applied to medicaments for resisting the HBV.

Description

technical field [0001] The invention relates to a siRNA used for treating HBV, which belongs to the field of genetic engineering. Background technique [0002] At present, there are about 420 million HBV carriers in the world, and HBV infection is one of the diseases that seriously affect human health. Chronic HBV infection is closely related to the occurrence of liver fibrosis and liver cancer. However, most of the chronic HBV patients did not get the expected results under conventional treatment. Although interferon can inhibit the replication of HBV, HBV can resist the anti-virus mechanism of the body by inhibiting the secretion and function of interferon, and finally lead the body to a state of immune tolerance. For example, in the peripheral blood and liver infiltrating cells of patients with chronic infection, the proportion of regulatory T cells was significantly increased. In addition, HBsAg, HBeAg, and other viral agents can directly suppress TLR-mediated innate ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/113A61P31/20
Inventor 田志刚韩秋菊张彩张建
Owner SHANDONG UNIV